GlassScriptPhysician profile
Bobbi Hintz
NPI 1659756377
$3,808.05
in general payments reported to CMS, 2019-2025
16 companies · $947 in 2025
The $947 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $598 · 2023: $1,420 · 2024: $491 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,786 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,785.63 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,151.16 | 2021-2024 | Dupixent, Libtayo |
| Ucb, INC. | $455.44 | 2024-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $368.66 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $356.19 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $291.08 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $276.75 | 2021-2023 | Ilumya, Blu-U, Odomzo |
| Janssen Biotech, INC. | $221.06 | 2021-2025 | Tremfya |
| Abbvie INC. | $180.44 | 2021-2025 | |
| Pfizer INC. | $145.62 | 2021-2022 | |
| Amgen INC. | $97.74 | 2023-2025 | Otezla, Otezla |
| Leo Pharma INC. | $94.84 | 2021-2025 | Adbry |
| Smith+Nephew, INC. | $70.86 | 2023 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Iodosorb Ointment 40g USA, Acticoat 4" X 4" |
| Galderma Laboratories, L.P. | $48.30 | 2021-2025 | Nemluvio |
| Journey Medical Corporation | $25.05 | 2025 | |
| Nabriva Therapeutics, Plc | $12.49 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $12.37 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobbi Hintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.